Southwell David P's Form 4 filing
TScan Therapeutics, Inc. (TCRX) · filed May 20, 2022
- Accession no.
- 0000899243-22-019018
- Filed
- May 20, 2022
- Trade date
- May 18, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $89.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Southwell David PCIK 0001251553 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | Voting Common Stock | PPurchaseAcquired | +15,000 | $3.62 | +$54,300 | 161,569 | Direct | |
| May 18, 2022 | Voting Common Stock | PPurchaseAcquired | +10,000 | $3.55 | +$35,500 | 171,569 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.